Skip to main content
Premium Trial:

Request an Annual Quote

Genomics Research to Play Role in $390M Aussie Gov't Biotech Initiative

This update corrects the headline, which erroneously suggested all of the Australian government fundung will go toward genomic research.
NEW YORK (GenomeWeb News) — Australia plans to pump AU$500 million ($389 million) into building research infrastructure and facilities for genomic analysis, gene discovery, and medical imaging, among other projects, according to the nation's Minister for Education, Science and Training.
The funding is part of a drive announced by Minister Julie Bishop that aims to take research discoveries made by Australian scientists from the lab and into the world.
The money will fund a National Collaborative Research Infrastructure Strategy, which Bishop said "will support emerging industries, such as nanotechnology and biotechnology products, underpin mature industries and help to address national challenges, such as generating sustainable energy and managing our natural resources.”  
In a statement, Bishop said that facilities are being developed in collaboration with the Australian government, state and territory governments, universities, research agencies and industry.
An additional AU$640 million in cash and in-kind contributions have been pledged so far for the facilities, in addition to the NCRIS funding, the statement said.

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.